Onkure Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
OnKure Therapeutics, Inc. has filed its proxy statement for the 2026 annual meeting of stockholders to be held on June 3, 2026.
NASDAQ
Onkure Therapeutics, Inc. has filed a definitive proxy statement with the SEC pursuant to Section 14(a) of the Securities Exchange Act of 1934.
NASDAQ
OnKure Therapeutics announces its 2025 annual meeting of stockholders to be held virtually on May 27, 2025, to elect directors and ratify the appointment of its independent auditor.